# Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)

> **NCT03195023** · PHASE4 · UNKNOWN · sponsor: **Hospital General Universitario Gregorio Marañon** · enrollment: 106 (estimated)

## Conditions studied

- Renal Insufficiency, Chronic
- Proteinuria

## Interventions

- **DRUG:** Lisinopril
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT03195023
- **Lead sponsor:** Hospital General Universitario Gregorio Marañon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2019-12
- **Final completion:** 2022-12
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2019-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03195023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03195023, "Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03195023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*